These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38769122)

  • 1. The role of USP7-YY1 interaction in promoting colorectal cancer growth and metastasis.
    Shao ZY; Yang WD; Qiu H; He ZH; Lu MR; Shen Q; Ding J; Zheng JN; Bai J
    Cell Death Dis; 2024 May; 15(5):347. PubMed ID: 38769122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer.
    Sato N; Sakai N; Furukawa K; Takayashiki T; Kuboki S; Takano S; Ohira G; Matsubara H; Ohtsuka M
    Oncol Rep; 2022 May; 47(5):. PubMed ID: 35266011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1.
    Zhang L; Dong X; Yan B; Yu W; Shan L
    Cell Death Dis; 2020 Jul; 11(7):542. PubMed ID: 32681092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mechanism of the oncogenic role of FGFR1 in papillary thyroid carcinoma.
    Li XB; Li JL; Wang C; Zhang Y; Li J
    Eur J Histochem; 2024 Jul; 68(3):. PubMed ID: 39037153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of transcription factor Yin Yang-1 in colorectal cancer.
    Shao Z; Yang W; Meng X; Li M; Hou P; Li Z; Chu S; Zheng J; Bai J
    Cancer Med; 2023 May; 12(10):11177-11190. PubMed ID: 36880159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.
    Ye Y; Gu B; Wang Y; Shen S; Huang W
    Cancer Biother Radiopharm; 2019 Oct; 34(8):519-528. PubMed ID: 31173500
    [No Abstract]   [Full Text] [Related]  

  • 8. CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.
    Pothoulakis C; Torre-Rojas M; Duran-Padilla MA; Gevorkian J; Zoras O; Chrysos E; Chalkiadakis G; Baritaki S
    Int J Cancer; 2018 Jan; 142(2):334-346. PubMed ID: 28929494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YY1 Silencing Induces 5-Fluorouracil-Resistance and
    Vivarelli S; Falzone L; Candido S; Bonavida B; Libra M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 ubiquitin ligase SMURF2 prevents colorectal cancer by reducing the stability of the YY1 protein and inhibiting the SENP1/c-myc axis.
    Gao Q; Wang S; Zhang Z
    Gene Ther; 2023 Feb; 30(1-2):51-63. PubMed ID: 34545207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.
    Tang W; Zhou W; Xiang L; Wu X; Zhang P; Wang J; Liu G; Zhang W; Peng Y; Huang X; Cai J; Bai Y; Bai L; Zhu W; Gu H; Xiong J; Ye C; Li A; Liu S; Wang J
    Nat Commun; 2019 Feb; 10(1):663. PubMed ID: 30737378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-κB/YY1 axis.
    Liu J; Zhan Y; Wang J; Wang J; Guo J; Kong D
    Mol Oncol; 2020 Dec; 14(12):3211-3233. PubMed ID: 33040438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition.
    Zhang Q; Liu H; Zhang J; Shan L; Yibureyimu B; Nurlan A; Aerxiding P; Luo Q
    Cell Reprogram; 2020 Dec; 22(6):328-336. PubMed ID: 33270501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription Factor yin-Yang 1 augments nucleoporin 93 oncogene activity and modulates bladder Cancer malignancy.
    Zhang G; Wei W; Li S; Yang J
    Toxicol In Vitro; 2024 Aug; 99():105875. PubMed ID: 38857852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated tumor progression.
    Liu H; Han J; Lv Y; Zhao Z; Zheng S; Sun Y; Sun T
    J Nanobiotechnology; 2023 Jul; 21(1):208. PubMed ID: 37408047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMEM97 is transcriptionally activated by YY1 and promotes colorectal cancer progression via the GSK-3β/β-catenin signaling pathway.
    Mao D; Zhang X; Wang Z; Xu G; Zhang Y
    Hum Cell; 2022 Sep; 35(5):1535-1546. PubMed ID: 35907137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27.
    Wan M; Huang W; Kute TE; Miller LD; Zhang Q; Hatcher H; Wang J; Stovall DB; Russell GB; Cao PD; Deng Z; Wang W; Zhang Q; Lei M; Torti SV; Akman SA; Sui G
    Am J Pathol; 2012 May; 180(5):2120-33. PubMed ID: 22440256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP7-mediated JUND suppresses RCAN2 transcription and elevates NFATC1 to enhance stem cell property in colorectal cancer.
    Chang Y; Chen L; Tang J; Chen G; Ji J; Xu M
    Cell Biol Toxicol; 2023 Dec; 39(6):3121-3140. PubMed ID: 37535148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating β-Catenin Deubiquitination.
    Novellasdemunt L; Foglizzo V; Cuadrado L; Antas P; Kucharska A; Encheva V; Snijders AP; Li VSW
    Cell Rep; 2017 Oct; 21(3):612-627. PubMed ID: 29045831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis.
    Zhang JJ; Zhu Y; Zhang XF; Liu DF; Wang Y; Yang C; Shi GD; Peng YP; Zhang K; Tian L; Miao Y; Jiang KR
    Cancer Lett; 2017 Nov; 408():144-154. PubMed ID: 28867247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.